Lakhani, N. J., Yoo, C., Schuster, C., Victoria, I., Yoon, J., Park, J. O., Celano, P., Guren, T. K., Groisberg, R., Shih, C., Jemielita, T., McKean, W. B. (2026). KANDLELIT-014: A phase 2 study of MK-1084 as monotherapy and in combination with cetuximab in KRAS G12C-mutant advanced solid tumors.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.tps3185